Amgen Secures License for New Drug

By staff-author

January 7, 2011

17

Amgen Inc. will license a new drug to treat autoimmune disease after reaching a deal with Xencor Inc. Amgen will have exclusive worldwide rights to the drug, known under the number XmAb5871, following the completion of a pre-defined Phase 2 study. The financial arrangement has Xencor, based in Monrovia, receiving $75 million for reaching up-front and early development milestones. Amgen would pay an additional $425 million in clinical, regulatory and commercialization milestone payments. The new drug will enhance Thousand Oaks-based Amgen’s internal efforts at developing treatments for inflammatory diseases. “Amgen’s long-time leadership in antibody development for oncology and inflammatory diseases aligns seamlessly with Xencor’s pipeline development,” said Xencor CEO Bassil Dahiyat. “The option deal structure allows us to continue to lead the development of XmAb5871 while also leveraging Amgen’s experience in developing novel biologics for unmet medical needs.” Mark R. Madler

Previous article

Douglas Emmett Names New Executive VP

Next article

Hertz Buys Filming Equipment Business

Featured Articles

Related Articles

' + // image style settings '
' + 'tagDiv image style' + '' + '
' + ''; //inject our settings in the template - before

td_template_content = td_template_content.replace('

', td_our_content + '

'); //save the template jQuery('#tmpl-image-details').html(td_template_content); //modal off - click event jQuery(document).on( "click", ".td-modal-image-on", function() { if (jQuery(this).hasClass('active')) { return; } td_add_image_css_class('td-modal-image'); jQuery(".td-modal-image-off").removeClass('active'); jQuery(".td-modal-image-on").addClass('active'); }); //modal on - click event jQuery(document).on( "click", ".td-modal-image-off", function() { if (jQuery(this).hasClass('active')) { return; } td_remove_image_css_class('td-modal-image'); jQuery(".td-modal-image-off").addClass('active'); jQuery(".td-modal-image-on").removeClass('active'); }); // select change event jQuery(document).on( "change", ".td-wp-image-style", function() { switch (jQuery( ".td-wp-image-style").val()) { default: td_clear_all_classes(); //except the modal one jQuery('*[data-setting="extraClasses"]').change(); //trigger the change event for backbonejs } }); //util functions to edit the image details in wp-admin function td_add_image_css_class(new_class) { var td_extra_classes_value = jQuery('*[data-setting="extraClasses"]').val(); jQuery('*[data-setting="extraClasses"]').val(td_extra_classes_value + ' ' + new_class); jQuery('*[data-setting="extraClasses"]').change(); //trigger the change event for backbonejs } function td_remove_image_css_class(new_class) { var td_extra_classes_value = jQuery('*[data-setting="extraClasses"]').val(); //try first with a space before the class var td_regex = new RegExp(" " + new_class,"g"); td_extra_classes_value = td_extra_classes_value.replace(td_regex, ''); var td_regex = new RegExp(new_class,"g"); td_extra_classes_value = td_extra_classes_value.replace(td_regex, ''); jQuery('*[data-setting="extraClasses"]').val(td_extra_classes_value); jQuery('*[data-setting="extraClasses"]').change(); //trigger the change event for backbonejs } //clears all classes except the modal image one function td_clear_all_classes() { var td_extra_classes_value = jQuery('*[data-setting="extraClasses"]').val(); if (td_extra_classes_value.indexOf('td-modal-image') > -1) { //we have the modal image one - keep it, remove the others jQuery('*[data-setting="extraClasses"]').val('td-modal-image'); } else { jQuery('*[data-setting="extraClasses"]').val(''); } } //monitor the backbone template for the current status of the picture setInterval(function(){ var td_extra_classes_value = jQuery('*[data-setting="extraClasses"]').val(); if (typeof td_extra_classes_value !== 'undefined' && td_extra_classes_value != '') { // if we have modal on, switch the toggle if (td_extra_classes_value.indexOf('td-modal-image') > -1) { jQuery(".td-modal-image-off").removeClass('active'); jQuery(".td-modal-image-on").addClass('active'); } } }, 1000); })(); //end anon function -->